Advisor Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1K Buy
56
+50
+833% +$536 ﹤0.01% 5176
2019
Q3
$0 Sell
6
-12
-67% -$107 ﹤0.01% 5392
2019
Q2
$0 Buy
18
+16
+800% +$164 ﹤0.01% 5334
2019
Q1
$0 Hold
2
﹤0.01% 5298
2018
Q4
$0 Hold
2
﹤0.01% 5198
2018
Q3
$0 Hold
2
﹤0.01% 5187
2018
Q2
$0 Sell
2
-23
-92% -$454 ﹤0.01% 5018
2018
Q1
$1K Hold
25
﹤0.01% 4838
2017
Q4
$1K Buy
25
+2
+9% +$102 ﹤0.01% 4845
2017
Q3
$1K Buy
+23
New +$1.41K ﹤0.01% 4709

Other funds holding PRTA

Advisor Group's PRTA Position: Q4 2019 in Review

Advisor Group increased its Prothena Corp (PRTA) stake by 833% in Q4 2019, buying an estimated $536 and bringing the position to 56 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5176.

Advisor Group first reported a position in PRTA in Q3 2017 and has held it in 10 quarters since. 141 funds tracked by Wall St. Rank hold PRTA as of Q4 2019.

  • Advisor Group held 56 shares of Prothena Corp worth $1K as of Q4 2019.
  • Advisor Group bought 50 Prothena Corp shares in Q4 2019, an estimated $536.
  • Prothena Corp made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5176 holding.
  • Advisor Group first reported a position in Prothena Corp in Q3 2017 and has held it in 10 quarters since.
  • 141 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.